Prosecution Insights
Prosecution Insights
20 pending office actions • 10 clients • 19 examiners • 16 art units • 0 of 20 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 20 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 20 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 11 (55%) |
| §102 only | 1 (5%) |
| §112 only | 1 (5%) |
| No statute on record | 7 (35%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VU, JAKE MINH | 2 | 40.5% | +27.6% |
| BAEK, BONG-SOOK | 1 | 41.3% | +69.3% |
| COLEMAN, BRENDA LIBBY | 1 | 74.7% | +15.7% |
| KIM, SEONG JONG | 1 | — | — |
| BOECKELMAN, JACOB A | 1 | 36.1% | +46.3% |
| SAEED, KAMAL A | 1 | 84.1% | +9.3% |
| REYNOLDS, FRED H | 1 | 33.0% | +39.2% |
| YOON, TAE H | 1 | 66.3% | +25.1% |
| ROGERS, JAMES WILLIAM | 1 | 46.3% | +21.8% |
| BARSKY, JARED | 1 | 50.2% | +23.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18219656 | COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES | VU, JAKE MINH | 154d overdue |
| 18387769 | METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE | BOECKELMAN, JACOB A | 5d overdue |
| 18648420 | ISO-OSMOTIC AND NEAR ISO-OSMOTIC OXYGEN THERAPEUTIC FORMULATIONS AND METHODS THEREOF | BAEK, BONG-SOOK | 4d overdue |
| 18233077 | PROTEIN-POLYMER NANOASSEMBLIES AND INTRACELLULAR PROTEIN DELIVERY | YOON, TAE H | 3d overdue |
| 18574248 | CRYSTALLINE POLYMORPHS OF EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR, AND COMPOSITIONS AND METHODS THEREOF | COLEMAN, BRENDA LIBBY | 2d overdue |
| 18208672 | PROTEIN-TEMPLATED SELF-ASSEMBLY OF A COVALENT POLYMER NETWORK FOR INTRACELLULAR TRAFFICKING AND TRACELESS RELEASE | ROGERS, JAMES WILLIAM | 12d |
| 18202033 | COMPOSITIONS OF BERBERINE URSODEOXYCHOLATE AND METHODS THEREOF FOR TREATING PRIMARY SCLEROSING CHOLANGITIS | BARSKY, JARED | 15d |
| 17616166 | COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES | VU, JAKE MINH | 16d |
| Art Unit | Apps |
|---|---|
| 1618 | 3 |
| 1624 | 2 |
| 1693 | 2 |
| 1611 | 1 |
| 1621 | 1 |
| 1655 | 1 |
| 1626 | 1 |
| 1658 | 1 |
| 1762 | 1 |
| 1628 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18648420 | ISO-OSMOTIC AND NEAR ISO-OSMOTIC OXYGEN THERAPEUTIC FORMULATIONS AND METHODS THEREOF | NuvOx Pharma LLC | BAEK, BONG-SOOK | 1611 | §103 | Non-Final OA | 4d overdue | Pending | Apr 28, 2024 |
| 18574248 | CRYSTALLINE POLYMORPHS OF EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR, AND COMPOSITIONS AND METHODS THEREOF | Crimson Biopharm Inc. | COLEMAN, BRENDA LIBBY | 1624 | Other | Non-Final OA | 2d overdue | Pending | Dec 26, 2023 |
| 18519269 | Pharmaceutical Mixture Comprising Amorphous Pitolisant | Alfred E. Tiefenbacher GmbH & Co. KG | KIM, SEONG JONG | 1621 | §103 | Non-Final OA | 18d overdue | Pending | Nov 27, 2023 |
| 18387769 | METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE | Shenzhen Hightide Biopharmaceutical, Ltd. | BOECKELMAN, JACOB A | 1655 | Other | Non-Final OA | 5d overdue | Pending | Nov 07, 2023 |
| 18287301 | FLUOROCARBON COMPOSITIONS AND METHODS FOR ENHANCING IMMUNOTHERAPY | NuvOx Pharma LLC | SAEED, KAMAL A | 1626 | Other | Non-Final OA | 60d overdue | Pending | Oct 18, 2023 |
| 18279931 | PHOTOCAGED CITRULLINE ANALOGS AND METHODS FOR SITE-SPECIFIC INCORPORATION OF CITRULLINE INTO PROTEINS | UNIVERSITY OF MASSACHUSETTS | REYNOLDS, FRED H | 1658 | §103 | Non-Final OA | 57d | Pending | Sep 01, 2023 |
| 18233077 | PROTEIN-POLYMER NANOASSEMBLIES AND INTRACELLULAR PROTEIN DELIVERY | UNIVERSITY OF MASSACHUSETTS | YOON, TAE H | 1762 | Other | Non-Final OA | 3d overdue | Pending | Aug 11, 2023 |
| 18219656 | COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES | Microvascular Therapeutics, LLC | VU, JAKE MINH | 1618 | §103 | Non-Final OA | 154d overdue | Pending | Jul 08, 2023 |
| 18208672 | PROTEIN-TEMPLATED SELF-ASSEMBLY OF A COVALENT POLYMER NETWORK FOR INTRACELLULAR TRAFFICKING AND TRACELESS RELEASE | UNIVERSITY OF MASSACHUSETTS | ROGERS, JAMES WILLIAM | 1618 | §103 | Non-Final OA | 12d | Pending | Jun 12, 2023 |
| 18202033 | COMPOSITIONS OF BERBERINE URSODEOXYCHOLATE AND METHODS THEREOF FOR TREATING PRIMARY SCLEROSING CHOLANGITIS | Shenzhen Hightide Biopharmaceutical Ltd. | BARSKY, JARED | 1628 | Other | Final Rejection | 15d | Pending | May 25, 2023 |
| 18134495 | BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF | Shenzhen Hightide Biopharmaceutical, Ltd. | WILLIS, DOUGLAS M | 1624 | §112 | Final Rejection | 42d | Pending | Apr 13, 2023 |
| 18088544 | POLYMERIC NANOPARTICLES AND DERIVATIVES THEREOF FOR NUCLEIC ACID BINDING AND DELIVERY | UNIVERSITY OF MASSACHUSETTS | POPA, ILEANA | 1633 | §103 | Final Rejection | 28d | Pending | Dec 24, 2022 |
| 18081604 | NANODEVICES AND METHODS FOR MEASURING BIOFLUIDIC FLOW USING A GRAPHENE-BASED MICROELECTRODE | UNIVERSITY OF MASSACHUSETTS | MONTGOMERY, MELISSA JO | 3791 | §102 | Final Rejection | 9d | Pending | Dec 14, 2022 |
| 18078924 | DODECAFLUOROPENTANE EMULSION AS A STROKE AND ISCHEMIA THERAPY | BIOVENTURES, LLC | SCHUBERG, LAURA J | 1631 | Other | Non-Final OA | 73d overdue | Pending | Dec 10, 2022 |
| 17910779 | CROSS-LINKED MEDICATION FOR TREATMENT OF CORONAVIRAL INFECTION AND METHOD OF TREATMENT | 1Globe Health Institute, Nanjing | SCHACHERMEYER, SAMANTHA LYNN | 1693 | §103 | Final Rejection | 56d overdue | Pending | Nov 09, 2022 |
| 17790697 | ALKYLATED NUCLEOSIDES, AND COMPOSITIONS AND METHODS THEREOF FOR NUCLEIC ACID DELIVERY | Microvascular Therapeutics, LLC | CHO, DAVID H | 1693 | §103 | Final Rejection | 19d overdue | Pending | Jul 01, 2022 |
| 17777363 | COMPOSITIONS AND METHODS FOR OPTOGENETIC IMMUNOTHERAPY | UNIVERSITY OF MASSACHUSETTS | SUNSHINE, HANNAH LOUISE | 1647 | §103 | Final Rejection | 5d overdue | Pending | May 17, 2022 |
| 17719015 | High-Density Flagellin-Displaying Virus-Like Particle As Vaccine Carrier | University of Rhode Island Board of Trustees | LOUNTOS, GEORGE THEMISTOCLIS | 1652 | §103 | Non-Final OA | 30d | Pending | Apr 12, 2022 |
| 17616166 | COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES | Microvascular Therapeutics, LLC | VU, JAKE MINH | 1618 | §103 | Final Rejection | 16d | Pending | Dec 02, 2021 |
| 17429297 | USE OF ACTIVATORS OF THE ARYL HYDROCARBON RECEPTOR FOR TREATING GLUTEN-INDUCED GASTROINTESTINAL DISEASES | Institut National De Recherche Pour L'Agriculture, L'Alimentation Et I'Environnement | XIE, XIAOZHEN | 1674 | Other | Non-Final OA | 134d overdue | Pending | Aug 06, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial